Development of multigene and regulated lentivirus vectors

Journal of Virology

Volumn 74, Issue 22, 2000, Pages 10589-10599

  Reiser, J ^a   Lai, Z ^a   Zhang, X Y ^a   Brady, R O ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GREEN FLUORESCENT PROTEIN; KANAMYCIN KINASE; POL PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

ARTICLE; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MULTIGENE FAMILY; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE;

ANIMALS; ANTIGENS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MICE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0033759915     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.22.10589-10599.2000     Document Type: Article

References (69)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
2. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
3. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
4. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death
5. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
6. A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line
7. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells
8. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms
9. A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity
10. HIV-1 reverse transcription. A termination step at the center of the genome
11. Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system
12. High mutation rate of a spleen necrosis virus-based retrovirus vector
13. A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread
14. Gene therapy for human immunodeficiency virus infection: Genetic antiviral strategies and targets for intervention
15. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system
16. A third-generation lentivirus vector with a conditional packaging system
17. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA
18. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus
19. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
20. Construction and in vitro properties of HIV-1 mutants with deletions in 'nonessential' genes
21. Transfer and expression of cloned genes using retroviral vectors
22. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol
23. Lentiviral vectors for gene therapy of cystic fibrosis
24. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector
25. 2 phase of the cell cycle by inhibiting p34(cdc2) activity
26. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette
27. Human immunodeficiency viruses regulated by alternative trans-activators: Genetic evidence for a novel non-transcriptional function of Tat in virion infectivity
28. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
29. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors
30. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
31. Lentiviral vectors: Regulated gene expression
32. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
33. Lentiviral gene transfer to the nonhuman primate brain
34. Graded transcriptional response to different concentrations of a single transactivator
35. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range
36. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
37. + cell line H9
38. Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector
39. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
40. Development of a self-inactivating lentivirus vector
41. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
42. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
43. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells
44. Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and applications to human gene therapy
45. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
46. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
47. Lentiviral vectors
48. Gene transfer vectors derived from equine infectious anemia virus
49. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
50. Efficient lentiviral transduction of liver requires cell cycling in vivo
51. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes
52. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells
53. Production of high-titer helper-free retroviruses by transient transfection
54. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
55. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity
56. Production and concentration of pseudotyped HIV-1-based gene transfer vectors
57. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles
58. Intrabody-mediated knockout of the high-affinity IL-2 receptor in primary human T cells using a bicistronic lentivirus vector
59. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus
60. Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent
61. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells
62. Selective production of transgenic mice using green fluorescent protein as a marker
63. Synchronization of human diploid flbroblasts at multiple stages of the cell cycle
64. Gene therapy - Promises, problems and prospects
65. Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector
66. Lentivirus vectors using human and simian immunodeficiency virus elements
67. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
68. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo